Skip to content

Clinical trials

Phase 3 Thrombosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombosis Phase: Phase 3 Country / region: United States Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20052
20066
20081
20094
20102
20121
20132
20141
20164
20171
20202
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting4
Terminated4
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARCA Biopharma, Inc.4
Regeneron Pharmaceuticals3
Sanofi3
Brigham and Women's Hospital2
The Medicines Company2
AstraZeneca1
Bayer1
Boston Scientific Corporation1
Chiesi Farmaceutici S.p.A.1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombosis34
Venous Thrombosis8
Stroke7
Pulmonary Embolism6
Thromboembolism6
Venous Thromboembolism6
Embolism5
Atrial Fibrillation4
Hemorrhage4
Cardiovascular Diseases3

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.